Clozapine and fluvoxamine, a curious complexity

被引:14
作者
Shader, RI
Greenblatt, DJ
机构
关键词
D O I
10.1097/00004714-199804000-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:101 / 102
页数:2
相关论文
共 21 条
[1]  
BRISEN K, 1995, CLIN PHARMACOKINE S1, V29, P20
[2]  
DEGUARDO JR, 1996, AM J PSYCHIAT, V153, P840
[3]   Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome [J].
Dolphin, CT ;
Janmohamed, A ;
Smith, RL ;
Shephard, EA ;
Phillips, IR .
NATURE GENETICS, 1997, 17 (04) :491-494
[4]  
Edge SC, 1997, HUM PSYCHOPHARM CLIN, V12, P5, DOI 10.1002/(SICI)1099-1077(199701/02)12:1<5::AID-HUP831>3.0.CO
[5]  
2-4
[6]   The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine [J].
Eiermann, B ;
Engel, G ;
Johansson, I ;
Zanger, UM ;
Bertilsson, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) :439-446
[7]  
Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356
[8]   DOSE-RELATED PLASMA-LEVELS OF CLOZAPINE - INFLUENCE OF SMOKING-BEHAVIOR, SEX AND AGE [J].
HARING, C ;
MEISE, U ;
HUMPEL, C ;
SARIA, A ;
FLEISCHHACKER, WW ;
HINTERHUBER, H .
PSYCHOPHARMACOLOGY, 1989, 99 :S38-S40
[9]  
HIEMKE C, 1994, J CLIN PSYCHOPHARM, V14, P279
[10]   FLUVOXAMINE INHIBITION AND CARBAMAZEPINE INDUCTION OF THE METABOLISM OF CLOZAPINE - EVIDENCE FROM A THERAPEUTIC DRUG-MONITORING SERVICE [J].
JERLING, M ;
LINDSTROM, L ;
BONDESSON, U ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1994, 16 (04) :368-374